Biological In Vitro Assays

Biological In Vitro Assays

Browse

Recent Submissions

Now showing 1 - 1 of 1
  • Item
    The Prevalence, Diagnosis, and Antifungal Susceptibility of Candida Species in Palestine
    (Al-Quds University, 2023-08-20) Hanaa Khairaldeen Mohammed Baniodeh; هناء خيرالدين محمد بنيعودة
    Background: Candida spp are the single most common cause of opportunistic fungal infection.Various healthcare implications are associated with Candida infections, including morbidity and mortality. The significantly increased occurrence of Candida species as human pathogens can be attributed to improved identification techniques. In Palestine, minimal data have been reported about Candida infection. Methods: We performed our study at two hospitals in Palestine ( Istishari Arab Hospital, and Najah National University Hospital ). All patients diagnosed with candidiasis during the year 2022 have participated in the study. The prevalence of Candida spp,their distribution and the activity of selected antifungals against Candida pathogens were statistically analyzed using Microsoft Excel Version (16.74). In combination with phenotypic properties, Candida isolates were identified and tested for antifungal susceptibility using the colorimetric VITEK-2 Compact system at two hospitals. Results : Our results showed that the prevalence of Candida spp among infected samples was 11.6%. Twelve different Candida spp were identified. Among these isolates, C. albicans (49.88%) was the most frequent, followed by C. glabrata (17.3%), C. tropicalis (14.83%), C. parapsilosis (5.16%), C. krusei (3.82%), C.auris(2.69%) ,C.dubliniensis (2.24%), C.ciferrii (1.79%) C.lusitaniae (0.89%), C. guilliermondii (0.67%), C.Kefyer (0.44%) and C.spherica(0.22%). Among C. albicans, all isolates were 100% susceptible to fluconazole, and micafungin .The susceptibility rates to Amphotericine B and flucytosine were 95 % and 99 % respectively. As a comparison, the susceptibility rates of non-albicans candida to fluconazole, voriconazole, amphotericine B, caspofungin ,flucytosine and micafungin were 70 %, 99 %, 97 %, ,72% , 92% and 100 %, respectively. Patients in the intensive care unit are more susceptible to candida infections than patients in other hospital departments. Conclusions: Four pathogens are responsible for the most invasive infections: Candida albicans, Candida glabrata, Candida tropicalis, and Candida parapsilosis. Those in an immunocompromised state are more likely to develop Candida infections. A notable characteristic of this study was the high frequency of non-albicans Candida Spp, which were often more resistant to antifungal agents. A quick and accurate system like Vitek 2 compact was suggested for careful species identification of clinical isolates of Candida. We suggest that continued surveillance of species distribution and susceptibility to antifungals will enhance future burden estimates and assist in evaluating preventative measures' effectiveness.